FDA Approves First Treatment for Rare Childhood Aging DiseasesApprovals, Business, Children, FDA, Hutchinson-Gilford Progeria Syndrome, Progeroid Laminopathies, TherapeuticsThe U.S. Food and Drug Administration approved Eiger BioPharmaceuticals’ Zokinvy for Hutchinson-Gilford Progeria Syndrome and processing-deficient Progeroid Laminopathies. Read more November 23, 2020/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/11/Giving-the-Gift-of-Time-FDA-Approves-First-Treatment-for-Rare-Childhood-Aging-Diseases-BioSpace-11-23-20.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2020-11-23 21:24:532020-11-24 23:02:39FDA Approves First Treatment for Rare Childhood Aging Diseases